NASD · Healthcare · Medical Devices · USA
LENSAR Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
LENSAR Inc designs and markets advanced laser systems for cataract treatment and corneal astigmatism management. The company's LENSAR Laser System and ALLY Robotic Cataract Laser System incorporate proprietary technologies to help surgeons achieve improved visual outcomes and procedural efficiency. These systems are available to cataract surgeons in the United States, European Union, and other markets.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the LENSAR Inc stock.
Undervalued: intrinsic value $6.50 per share, market price $4.91, margin of safety 24.5% (as of 2026-11-17).
A 1.4x revenue multiple, discounted for its losses, values the shares at $6.50; the price of $4.91 is 24% below that value.
5 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
6 more in this industry show a wider margin of safety.
LNSR is undervalued (as of the 2026-11-17 close). A 1.4x revenue multiple, discounted for its losses, values the shares at $6.50; the price of $4.91 is 24% below that value.
$6.50 per share (as of the 2026-11-17 close), against a market price of $4.91. That is a margin of safety of 24.5%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.